Hepatic insulin retention depends on influx in both diabetic and normal dogs

Hepatic retention of endogenous and exogenous insulin was investigated in normal and alloxanstreptozotocin diabetic dogs. An hour's peripheral venous infusion of insulin was preceded and followed by saline infusion. Blood samples were drawn simultaneously from the femoral artery and portal, hepatic and peripheral veins. Blood flow was measured electromagnetically in the portal vein and hepatic artery. Hepatic plasma flow was lower in diabetic dogs (p less than 0.001) so that prior to insulin infusion (basal hour) basal mean hepatic venous flux was diminished in them. Hepatic glucose production was higher (p less than 0.05) and arterio-venous glucose difference lower (p less than 0.01) in diabetics basally, but post-insulin infusion, these became similar in diabetics and normals. Although basal hour arterial and peripheral venous insulin concentrations were similar, portal venous insulin was 3.5-fold lower in diabetics. Mean insulin influx (hepatic arterial + portal venous fluxes) was four-fold lower in diabetics. The insulin net flux (influx - hepatic venous flux) was lower in diabetics (p less than 0.05) as was % extraction (p less than 0.001). During the insulin infusion hour the values remained lower for diabetics (p less than 0.05) for influx, net flux and % extraction. During the post-insulin infusion hour the influx, net flux and % extraction became similar. When the basal hour data in normals was restricted to the range of diabetic insulin influx values less than or equal to 10 mU X min-1, the differences in net flux and % extraction between normals and diabetics were no longer present.(ABSTRACT TRUNCATED AT 250 WORDS)

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.